Congratulations to our client NeuroDerm Ltd, on achievement of highly positive results from their pivotal clinical trial for Parkinson’s disease treatment.
The phase III trial of the drug-device combination therapy was crowned as a great success, bringing NeuroDerm Ltd a step closer to improving the lives of millions of Parkinson’s disease patients.
Well done!
For the full article click here